EP3082775A4 - Extruded extended release abuse deterrent pill - Google Patents
Extruded extended release abuse deterrent pill Download PDFInfo
- Publication number
- EP3082775A4 EP3082775A4 EP14871095.7A EP14871095A EP3082775A4 EP 3082775 A4 EP3082775 A4 EP 3082775A4 EP 14871095 A EP14871095 A EP 14871095A EP 3082775 A4 EP3082775 A4 EP 3082775A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- extended release
- abuse deterrent
- release abuse
- deterrent pill
- extruded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361917120P | 2013-12-17 | 2013-12-17 | |
US201361917074P | 2013-12-17 | 2013-12-17 | |
US201461980254P | 2014-04-16 | 2014-04-16 | |
US201461980259P | 2014-04-16 | 2014-04-16 | |
US14/457,714 US10195153B2 (en) | 2013-08-12 | 2014-08-12 | Extruded immediate release abuse deterrent pill |
PCT/US2014/070942 WO2015095387A1 (en) | 2013-12-17 | 2014-12-17 | Extruded extended release abuse deterrent pill |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3082775A1 EP3082775A1 (en) | 2016-10-26 |
EP3082775A4 true EP3082775A4 (en) | 2017-05-17 |
Family
ID=53403652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14871095.7A Withdrawn EP3082775A4 (en) | 2013-12-17 | 2014-12-17 | Extruded extended release abuse deterrent pill |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3082775A4 (en) |
JP (2) | JP6403780B2 (en) |
AU (3) | AU2014364800A1 (en) |
CA (1) | CA2934078C (en) |
WO (1) | WO2015095387A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049384A1 (en) * | 1996-06-26 | 1997-12-31 | Board Of Regents, The University Of Texas System | Hot-melt extrudable pharmaceutical formulation |
WO2010140007A2 (en) * | 2009-06-05 | 2010-12-09 | Euro-Celtique S.A. | Dosage form |
US20130028970A1 (en) * | 2011-07-29 | 2013-01-31 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US20140010873A1 (en) * | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
WO2015023675A2 (en) * | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR049562A1 (en) * | 2004-07-01 | 2006-08-16 | Gruenenthal Gmbh | ORAL PHARMACEUTICAL FORMS, WITH CONTROLLED OPIOID RELEASE, PROTECTED AGAINST ABUSE AND PROCEDURE FOR PREPARATION |
US20080152595A1 (en) * | 2004-11-24 | 2008-06-26 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
DE102007011485A1 (en) * | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Dosage form with more difficult abuse |
WO2013158810A1 (en) * | 2012-04-18 | 2013-10-24 | Mallinckrodt Llc | Immediate release pharmaceutical compositions with abuse deterrent properties |
-
2014
- 2014-12-17 EP EP14871095.7A patent/EP3082775A4/en not_active Withdrawn
- 2014-12-17 JP JP2016540580A patent/JP6403780B2/en not_active Expired - Fee Related
- 2014-12-17 AU AU2014364800A patent/AU2014364800A1/en not_active Abandoned
- 2014-12-17 CA CA2934078A patent/CA2934078C/en not_active Expired - Fee Related
- 2014-12-17 WO PCT/US2014/070942 patent/WO2015095387A1/en active Application Filing
-
2018
- 2018-09-11 JP JP2018169278A patent/JP6678212B2/en not_active Expired - Fee Related
- 2018-10-25 AU AU2018253567A patent/AU2018253567B2/en not_active Ceased
-
2019
- 2019-08-16 AU AU2019216710A patent/AU2019216710A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997049384A1 (en) * | 1996-06-26 | 1997-12-31 | Board Of Regents, The University Of Texas System | Hot-melt extrudable pharmaceutical formulation |
WO2010140007A2 (en) * | 2009-06-05 | 2010-12-09 | Euro-Celtique S.A. | Dosage form |
US20130028970A1 (en) * | 2011-07-29 | 2013-01-31 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
US20140010873A1 (en) * | 2012-07-06 | 2014-01-09 | Egalet Ltd. | Abuse deterrent pharmaceutical compositions for controlled release |
WO2015023675A2 (en) * | 2013-08-12 | 2015-02-19 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
Non-Patent Citations (1)
Title |
---|
See also references of WO2015095387A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2019001816A (en) | 2019-01-10 |
JP6403780B2 (en) | 2018-10-10 |
CA2934078C (en) | 2019-08-06 |
JP6678212B2 (en) | 2020-04-08 |
CA2934078A1 (en) | 2015-06-25 |
AU2014364800A1 (en) | 2016-07-07 |
WO2015095387A1 (en) | 2015-06-25 |
AU2018253567B2 (en) | 2019-05-23 |
EP3082775A1 (en) | 2016-10-26 |
AU2018253567A1 (en) | 2018-11-08 |
JP2017503780A (en) | 2017-02-02 |
AU2019216710A1 (en) | 2019-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3003271A4 (en) | Abuse deterrent immediate release formulation | |
EP3039046A4 (en) | Polyanionic polymers | |
EP3030566A4 (en) | Aza-pyridone compounds and uses thereof | |
EP3090423A4 (en) | Physical object discovery | |
EP2968182B8 (en) | Abuse deterrent solid dosage form for immediate release with functional score | |
EP3008094A4 (en) | Bis-biotinylation tags | |
EP3030213A4 (en) | Pill feeder | |
EP3055288A4 (en) | Antidiabetic tricyclic compounds | |
EP3003039A4 (en) | Methyl/fluoro-pyridinyl-methoxy substituted pyridinone-pyridinyl compounds and fluoro-pyrimidinyl-methoxy substituted pyridinone-pyridinyl compounds | |
EP3088283A4 (en) | Blinker device | |
EP3030519A4 (en) | Tricyclic benzoxaborole compounds and uses thereof | |
EP3068768A4 (en) | Antidiabetic tricyclic compounds | |
EP3057621A4 (en) | Polymeric radiation-sources | |
EP3094785A4 (en) | Hydrofission barrier | |
EP3068388A4 (en) | Neuroprotective compounds and use thereof | |
EP2991648A4 (en) | Antimicrobial potentiators | |
EP3062778A4 (en) | Immediate release abuse-deterrent granulated dosage forms | |
EP3031607A4 (en) | Multilayer molding | |
EP3048923B8 (en) | Protection device with symmetry mechanism | |
EP3053943A4 (en) | Ultraviolet-ray-absorbing polycarbonate | |
GB201600342D0 (en) | Chewable tablet | |
EP3069714A4 (en) | Tablet | |
EP3087240A4 (en) | Spacing mechanism | |
EP3082775A4 (en) | Extruded extended release abuse deterrent pill | |
EP3032948A4 (en) | Extruded immediate release abuse deterrent pill |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20160713 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20170413 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 25/36 20060101ALI20170408BHEP Ipc: A61K 9/22 20060101AFI20170408BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180605 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20210112 |